Star Imaging And Path Lab Current Share Price | Star Imaging And Path Lab Stock Screener
STARIMAGIN
Healthcare Service Provider
Star Imaging And Path Lab Current Stock Price Today
Track the current Star Imaging And Path Lab share price and stock price live with TickJournal's free stock screener.
Browse Star Imaging And Path Lab financial data to support your investment research.
Use the Star Imaging And Path Lab stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Star Imaging And Path Lab Market Cap
₹134.60 Cr.
STARIMAGIN P/E Ratio (TTM)
-
Star Imaging And Path Lab P/B Ratio
1.22
EPS (TTM)
₹11.05
Dividend Yield
-
Debt to Equity
0.81
STARIMAGIN 52 Week High
-
Star Imaging And Path Lab 52 Week Low
-
Operating Margin
-
Profit Margin
-
STARIMAGIN Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹154.00
Total Equity
₹116.00
Star Imaging And Path Lab Current Share Price Chart
Track the current Star Imaging And Path Lab share price and stock price with an interactive chart. Analyse STARIMAGIN price trends, trading volume, historical performance, and volatility across different timeframes — the complete Star Imaging And Path Lab stock quote in one place.
Star Imaging And Path Lab Company Profile - Fundamental Screener
Screen Star Imaging And Path Lab company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for STARIMAGIN shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0YG001013
Star Imaging And Path Lab Balance Sheet Screener
Screen STARIMAGIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 154 | 98 | 82 | 61 | 58 |
| Current Assets | 115 | 67 | 53 | 26 | 32 |
| Fixed Assets | 25 | 21 | 22 | 19 | 15 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 9 | 17 | 18 | 16 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 116 | 47 | 31 | 19 | 18 |
| Share Capital | 17 | 14 | 2 | 2 | 2 |
| Reserves & Surplus | 99 | 34 | 30 | 17 | 17 |
Star Imaging And Path Lab Income Statement Screener - Profit & Revenue Analysis
Screen Star Imaging And Path Lab income statement and profit fundamentals.
Analyze STARIMAGIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Star Imaging And Path Lab share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 89 | 84 | 80 | 59 | 69 |
| Expenses | 0 | 55 | 55 | 56 | 53 | 54 |
| EBITDA | 0 | 33 | 29 | 24 | 6 | 15 |
| Operating Profit % | 0.00% | 37.00% | 34.00% | 29.00% | 10.00% | 21.00% |
| Depreciation | 0 | 6 | 5 | 5 | 3 | 4 |
| Interest | 0 | 2 | 3 | 2 | 2 | 2 |
| Profit Before Tax | 0 | 26 | 21 | 16 | 1 | 9 |
| Tax | 0 | 7 | 6 | 4 | 0 | 3 |
| Net Profit | 0 | 19 | 16 | 13 | 1 | 6 |
| EPS | 0.00 | 11.05 | 11.80 | 82.78 | 3.89 | 41.95 |
Star Imaging And Path Lab Cash Flow Screener - Liquidity Fundamentals
Screen STARIMAGIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | -6 | 18 | 5 | 14 |
| Investing Activities | -4 | -7 | -7 | -4 |
| Financing Activities | 0 | 2 | -5 | -7 |
| Net Cash Flow | -10 | 13 | -7 | 3 |
Star Imaging And Path Lab Shareholding Pattern Screener
See Star Imaging And Path Lab shareholding pattern with promoter, FII, and DII holdings.
Check Star Imaging And Path Lab promoter holding and ownership changes for STARIMAGIN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Aug | 2025-Sept |
|---|---|---|---|---|
| Promoter Holding | 71.92% | 100.00% | 71.92% | 71.92% |
| FII Holding | 0.61% | 0.00% | 1.18% | 1.37% |
| DII Holding | 6.14% | 0.00% | 11.44% | 9.33% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.17% | 0.00% | 11.01% | 12.30% |
| Other Holding | 5.16% | 0.00% | 4.46% | 5.08% |
| Shareholder Count | 773 | 7 | 7 | 779 |
Star Imaging And Path Lab Share Dividend Screener - Share Yield Analysis
Check Star Imaging And Path Lab dividend history with payout and yield data.
View Star Imaging And Path Lab dividend details including ex-dates and amounts for STARIMAGIN stock.
Star Imaging And Path Lab Stock Index Membership
See which indices include Star Imaging And Path Lab stock.
Check STARIMAGIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Star Imaging And Path Lab Market Events Screener - Corporate Actions
Get Star Imaging And Path Lab corporate actions including splits, bonuses, and buybacks.
Check Star Imaging And Path Lab stock events that may affect STARIMAGIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -9.35% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | -1.26% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.33% |
Star Imaging And Path Lab Competitors Screener - Peer Comparison
Screen STARIMAGIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 31,958 | 58.66 | 2,864 | 12.11% | 510 | 52.85 |
| Vijaya Diagnostic Centre | 14,855 | 82.54 | 835 | 19.34% | 173 | 44.95 |
| Metropolis Healthcare | 11,870 | 59.91 | 1,671 | 24.15% | 191 | 48.12 |
| Thyrocare Technologies | 8,666 | 49.62 | 846 | 20.48% | 163 | 37.31 |
| Nephrocare Health Services | 7,375 | 90.61 | 1,023 | 32.93% | 77 | 57.75 |
| Krsnaa Diagnostics | 1,757 | 18.39 | 773 | 4.05% | 106 | 43.89 |
| Suraksha Diagnostic | 1,682 | 48.15 | 314 | 22.55% | 31 | 54.61 |
| 3B BlackBio DX | 1,164 | 21.72 | 142 | 27.17% | 61 | 49.35 |
| One Global Service Provider | 1,013 | 14.36 | 499 | 237.48% | 70 | 39.84 |
| Health X Platform | 972 | -37.44 | 1,319 | 12.68% | -3 | 53.22 |
Star Imaging And Path Lab Company Announcements - News Screener
Screen STARIMAGIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-01 | Web-Link To Access The Annual Report-2025-26 | - |
| 2026-09-01 | Notice Of 22Nd Annual General Meeting (AGM) Of The Company For The Financial Year 2025-26 | - |
| 2026-09-01 | Reg. 34 (1) Annual Report. | - |
| 2026-08-28 | Outcome Of The Board Meeting Held On Friday August 28 2026 | - |
| 2026-08-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday August 28 2026 | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-08 | Intimation Under Regulation 30 - Upgradation Of Tilak Nagar Diagnostic Centre With Toshiba Aquilion ONE 1184 Slice/Second CT Scanner | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-25 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-22 | Outcome Of The Board Meeting Held Today I.E. Friday 22 May 2026 | - |
| 2026-05-22 | Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Friday 22 May 2026 | - |
| 2026-05-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-15 | Board Meeting Intimation for To Consider And Approve Audited (Standalone And Consolidated) Financial Results Of The Company For The Half And Financial Year Ended March 31 2026. | - |
| 2026-05-14 | Intimation For Appointment Of Investor And Public Relations Agency Of The Company Under The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-08 | Annual Disclosure Confirming Non-Applicability Pertaining To Fund Raising By Issuance Of Debt Securities By Large Entities | - |